Amoéba Future Growth
Future criteria checks 2/6
Amoéba is forecast to grow earnings and revenue by 51.2% and 41.4% per annum respectively.
Key information
51.2%
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 10.3% |
Revenue growth rate | 41.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4 | N/A | N/A | N/A | 1 |
12/31/2025 | 1 | -6 | -8 | N/A | 1 |
12/31/2023 | N/A | -14 | N/A | N/A | N/A |
9/30/2023 | N/A | -11 | N/A | N/A | N/A |
6/30/2023 | N/A | -7 | -6 | -4 | N/A |
3/31/2023 | N/A | -8 | -5 | -4 | N/A |
12/31/2022 | N/A | -8 | -5 | -4 | N/A |
9/30/2022 | N/A | -8 | -5 | -4 | N/A |
6/30/2022 | N/A | -8 | -5 | -5 | N/A |
3/31/2022 | N/A | -8 | -5 | -4 | N/A |
12/31/2021 | N/A | -8 | -4 | -4 | N/A |
9/30/2021 | N/A | -8 | -4 | -4 | N/A |
6/30/2021 | N/A | -8 | -4 | -4 | N/A |
3/31/2021 | N/A | -8 | -4 | -4 | N/A |
12/31/2020 | N/A | -8 | -3 | -3 | N/A |
9/30/2020 | 0 | -7 | -3 | -3 | N/A |
6/30/2020 | 0 | -7 | -3 | -3 | N/A |
3/31/2020 | 0 | -7 | -3 | -3 | N/A |
12/31/2019 | 0 | -7 | -4 | -3 | N/A |
9/30/2019 | 0 | -7 | -4 | -4 | N/A |
6/30/2019 | 0 | -7 | -4 | -4 | N/A |
3/31/2019 | 0 | -7 | -5 | -5 | N/A |
12/31/2018 | 0 | -7 | -6 | -5 | N/A |
9/30/2018 | 0 | -7 | -6 | -6 | N/A |
6/30/2018 | 0 | -7 | -6 | -6 | N/A |
3/31/2018 | 0 | -7 | -6 | -5 | N/A |
12/31/2017 | 0 | -6 | -6 | -5 | N/A |
9/30/2017 | 0 | -6 | N/A | -5 | N/A |
6/30/2017 | 0 | -6 | N/A | -5 | N/A |
3/31/2017 | 0 | -6 | N/A | -5 | N/A |
12/31/2016 | 0 | -6 | N/A | -6 | N/A |
9/30/2016 | 0 | -6 | N/A | -6 | N/A |
6/30/2016 | 0 | -5 | N/A | -6 | N/A |
3/31/2016 | 0 | -5 | N/A | -5 | N/A |
12/31/2015 | 0 | -4 | N/A | -4 | N/A |
9/30/2015 | 0 | -3 | N/A | -3 | N/A |
6/30/2015 | 0 | -2 | N/A | -2 | N/A |
3/31/2015 | 0 | -2 | N/A | -1 | N/A |
12/31/2014 | 0 | -1 | N/A | -1 | N/A |
12/31/2013 | 0 | -1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALMIB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALMIB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALMIB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALMIB's revenue (41.4% per year) is forecast to grow faster than the French market (5.7% per year).
High Growth Revenue: ALMIB's revenue (41.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALMIB's Return on Equity is forecast to be high in 3 years time